Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Entyvio 300 mg powder for concentrate for solution for infusion

Active Ingredient:
vedolizumab
Company:  
Takeda UK Ltd See contact details
ATC code: 
L04AA33
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 26 Sep 2023
{pdf} View or print the patient leaflet as PDF
Takeda UK Ltd
Company image
Address
1 Kingdom Street, London, W2 6BD, UK
WWW
www.takeda.com/en-gb/
Telephone
+44 (0)3333 000 181
Medical Information Direct Line
+44 (0)3333 000 181
Medical Information e-mail
[email protected]
Drug Safety e-mail
[email protected]